Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FGFR1 | P11362 | 3/20 | 0.51 |
| ▸ | STING1 | Q86WV6 | 2/20 | 0.42 |
| ▸ | LMNA | P02545 | 3/20 | 0.38 |
| ▸ | PDE3A | Q14432 | 3/20 | 0.38 |
| ▸ | CACNA1F | O60840 | 2/20 | 0.38 |
| ▸ | ALB | P02768 | 2/20 | 0.38 |
| ▸ | MAPT | P10636 | 2/20 | 0.38 |
| ▸ | CACNA1D | Q01668 | 2/20 | 0.38 |
| ▸ | CACNA1S | Q13698 | 2/20 | 0.38 |
| ▸ | CACNA1C | Q13936 | 2/20 | 0.38 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.38 |
| ▸ | POLG | P54098 | 2/20 | 0.37 |
| ▸ | POLB | P06746 | 1/20 | 0.37 |
| ▸ | THRB | P10828 | 1/20 | 0.35 |
| ▸ | MTOR | P42345 | 1/20 | 0.35 |
| ▸ | MDM2 | Q00987 | 1/20 | 0.35 |
| ▸ | NCOA1 | Q15788 | 1/20 | 0.35 |
| ▸ | NCOA3 | Q9Y6Q9 | 1/20 | 0.35 |
| ▸ | PDE4D | Q08499 | 1/20 | 0.34 |
| ▸ | SLC29A1 | Q99808 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL24625409 | 1.00 | FGFR1 (0.51) | FGFR1STING1LMNAPDE3ACACNA1F | |
| SCHEMBL23610456 | 0.82 | STING1 (0.42) | FGFR1STING1LMNAPDE3ACACNA1F | |
| SCHEMBL20180446 | 0.82 | STING1 (0.42) | FGFR1STING1LMNAPDE3ACACNA1F | |
| SCHEMBL20709857 | 0.82 | FGFR1 (0.47) | FGFR1LMNAPDE3ACACNA1FALB | |
| SCHEMBL20709883 | 0.82 | FGFR1 (0.47) | FGFR1LMNAPDE3ACACNA1FALB | |
| SCHEMBL20709830 | 0.82 | FGFR1 (0.47) | FGFR1LMNAPDE3ACACNA1FALB | |
| SCHEMBL20709886 | 0.82 | FGFR1 (0.47) | FGFR1LMNAPDE3ACACNA1FALB | |
| SCHEMBL20709885 | 0.82 | FGFR1 (0.47) | FGFR1LMNAPDE3ACACNA1FALB | |
| SCHEMBL20709829 | 0.82 | FGFR1 (0.47) | FGFR1LMNAPDE3ACACNA1FALB | |
| SCHEMBL23105029 | 0.81 | POLG (0.40) | FGFR1STING1LMNAPDE3ACACNA1F |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20220220145-A1 | CYCLIC PHOSPHATE COMPOUNDS | CITIBANK, N.A., AS ADMINISTRATIVE AGENT | 2022-07-14 | — | — | US | disclosed |
| US-20220220145-A1 | CYCLIC PHOSPHATE COMPOUNDS | CITIBANK, N.A., AS ADMINISTRATIVE AGENT | 2022-07-14 | — | — | US | disclosed |
| EP-3966221-A1 | CYCLIC PHOSPHATE COMPOUNDS | Ligand Pharmaceuticals Incorporated (US) | 2022-03-16 | — | — | EP | disclosed |
| CN-113939526-A | Cyclic phosphate ester compound | 配体药物公司 | 2022-01-14 | — | — | CN | disclosed |
| WO-2020219464-A1 | CYCLIC PHOSPHATE COMPOUNDS | LIGAND PHARMACEUTICALS, INC. (US) | 2020-10-29 | — | — | WO | disclosed |
| WO-2020219464-A1 | CYCLIC PHOSPHATE COMPOUNDS | LIGAND PHARMACEUTICALS, INC. (US) | 2020-10-29 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220220145-A1 | CYCLIC PHOSPHATE COMPOUNDS | PYGL, ALPP, PHPT1 | FGFR1 907/4885STING1 1471/4885LMNA 2536/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.